Sickle cell disease: the case for coordinated information.
作者信息
Streetly A, Dick M, Layton M
出版信息
BMJ. 1993 Jun 5;306(6891):1491-2. doi: 10.1136/bmj.306.6891.1491.
Abstract
摘要
相似文献
1
Sickle cell disease: the case for coordinated information.
BMJ. 1993 Jun 5;306(6891):1491-2. doi: 10.1136/bmj.306.6891.1491.
2
Nurses are key to sickle cell screening.
Nurs Times. 2004;100(35):18.
3
Screening for sickle cell disease and thalassaemia saving lives.
BMJ. 2004 Jul 10;329(7457):69. doi: 10.1136/bmj.329.7457.69-a.
4
The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
Pediatr Blood Cancer. 2016 Jan;63(1):168-70. doi: 10.1002/pbc.25706. Epub 2015 Aug 14.
5
Sickle cell and thalassaemia screening: early care.
Pract Midwife. 2007 Oct;10(9):22-5.
6
The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey.
Saudi Med J. 2009 Mar;30(3):452: author reply 452.
7
Sickle-cell disease: a call to action.
Trans R Soc Trop Med Hyg. 2015 Jun;109(6):355-6. doi: 10.1093/trstmh/trv035.
8
Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
Health Technol Assess. 2000;4(3):i-v, 1-99.
9
[Selective neonatal screening for sickle cell disease].
An Pediatr (Barc). 2008 Apr;68(4):407-8. doi: 10.1157/13117720.
10
[Neonatal screening of sickle cell disease in France].
Arch Pediatr. 2008 Jun;15(5):738-40. doi: 10.1016/S0929-693X(08)71894-3.
引用本文的文献
1
Experiences of hospital care and treatment-seeking behavior for pain from sickle cell disease: qualitative study.
West J Med. 1999 Nov;171(5-6):306-13.
2
A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports.
BMJ. 2000 May 20;320(7246):1353-4. doi: 10.1136/bmj.320.7246.1353.
3
Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study.
BMJ. 1999 Jun 12;318(7198):1585-90. doi: 10.1136/bmj.318.7198.1585.
4
Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London.
BMJ. 1994 Aug 6;309(6951):372-4. doi: 10.1136/bmj.309.6951.372.
5
Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke.
Eur J Pediatr. 1995 Feb;154(2):150-6.
本文引用的文献
1
Newborn screening for sickle cell disease: effect on mortality.
Pediatrics. 1988 Jun;81(6):749-55.
2
Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.
Br Med J (Clin Res Ed). 1986 Mar 15;292(6522):737-40. doi: 10.1136/bmj.292.6522.737.
3
Assessment of care of children with sickle cell disease: implications for neonatal screening programmes.
BMJ. 1990 Feb 10;300(6721):371-4. doi: 10.1136/bmj.300.6721.371.
4
Patterns of mortality in sickle cell disease in the United Kingdom.
J Clin Pathol. 1991 Jun;44(6):459-63. doi: 10.1136/jcp.44.6.459.
5
Review of neonatal screening programme for phenylketonuria.
BMJ. 1991 Aug 10;303(6798):333-5. doi: 10.1136/bmj.303.6798.333.
6
Neonatal screening for sickle cell disease: a cost-effectiveness analysis.
J Pediatr. 1991 Apr;118(4 Pt 1):546-54. doi: 10.1016/s0022-3476(05)83375-x.
7
The vaso-occlusive crisis of sickle cell disease.
BMJ. 1991 Jun 29;302(6792):1551-2. doi: 10.1136/bmj.302.6792.1551.
8
Cost-effectiveness of neonatal screening for sickle cell disease.
J Pediatr. 1992 Jan;120(1):162-3. doi: 10.1016/s0022-3476(05)80628-6.
9
Using a mock trial to make a difficult clinical decision.
BMJ. 1992 Nov 21;305(6864):1284-7. doi: 10.1136/bmj.305.6864.1284.
Zotero 插件